Daily analysis of Indian market events grounded in real corporate filings. Every claim is backed by what companies actually said in their annual reports and quarterly results.
RBI approved Kotak Mahindra Bank to acquire up to 9.99% stakes in Federal Bank, AU Small Finance Bank, J&K Bank, and City Union Bank. We dig into filings to find out what this means for investors.
Crude oil tumbled 7% on US-Iran breakthrough hopes, sending Sensex up 940 points. But the real story is in company filings — these five stocks stand to gain the most from sustained lower oil prices.
Sun Pharma explores a $12B Organon acquisition. Filing data reveals what this means for its balance sheet and which rival pharma stocks could benefit from the distraction.
As crude oil volatility crushes refining margins at IOC, BPCL, HPCL, and MRPL, city gas companies GAIL, IGL, and MGL are quietly posting record volumes and profits.
The UAE leaving OPEC could push crude lower. Filing data shows paint, tyre, and packaging companies stand to gain the most from cheaper oil-linked raw materials.
India reimposed export duties on diesel and ATF to keep domestic fuel supply stable as crude surges to $120. Filing data reveals which refiners are most exposed and why IndiGo may benefit.
The government's push to recognize higher ethanol-blended fuels is a game-changer for sugar companies that have invested billions in distillery capacity. We dig into the filings.
The India-New Zealand Free Trade Agreement eliminates tariffs on 100% of Indian exports. We dig into filings to find the textile, jewellery, and footwear companies best positioned to benefit.
Sun Pharma's record acquisition of Organon validates Indian pharma's global ambitions. Here are five companies positioned to benefit from the sector's biggest-ever deal.
The US imposed 123% preliminary anti-dumping duties on Indian solar module imports. We dig into filings of Premier Energies, Waaree, Borosil Renewables and others to assess the damage.
Brent crude crosses $100 amid Middle East tensions. We dug into filings of upstream producers, refiners, paint makers, and tyre companies to separate the real winners from the real losers.
India's LPG rationing amid West Asia tensions creates clear winners in pharma and food processing while squeezing ceramics and glass manufacturers. Here's what filings reveal about which companies are exposed.
A US tariff refund window could channel $10-12 billion to Indian exporters. We dug into filings to find which textile, jewellery, and pharma companies are best positioned.
The RBI's relaxation of risk-weight norms on bank lending to NBFCs frees up capital for MSME credit. We dug into filings to find which banks and NBFCs have the biggest SME books and the most to gain.
As West Asia oil risks mount, India is accelerating its E85 flex-fuel vehicle policy. The biggest winners may not be automakers — they're sugar-ethanol companies that have been quietly expanding distillery capacity for years.